Guggenheim maintains a Buy rating on Phibro Animal Health Corp. (NASDAQ: PAHC), and raised the price target to $40.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE